Bajaj Healthcare Share Price
Sector: Biotechnology & Drugs
518.90 -4.40 (-0.84%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
518.05
Today’s High
527.50
52 Week Low
312.70
52 Week High
744.90
519.50 -4.05 (-0.77%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
517.00
Today’s High
527.35
52 Week Low
312.00
52 Week High
745.00
Key Metrics
- Market Cap (In Cr) 1639.16
- Beta 1.09
- Div. Yield (%) 0.19
- P/B 3.52
- TTM P/E 47.17
- Sector P/E 22.43
- D/E 0
- Open Price 523.7
- Prev Close 523.3
Bajaj Healthcare Analysis
Price Analysis
-
1 Week-2.41%
-
3 Months-22.49%
-
6 Month-6.15%
-
YTD-9.4%
-
1 Year55.77%
Risk Meter
- 65% Low risk
- 65% Moderate risk
- 65% Balanced Risk
- 65% High risk
- 65% Extreme risk
Bajaj Healthcare News
Q4 results today: GIC, Aurobindo Pharma, Sumitomo Chemical, Nazara Tech, more
1 min read . 26 May 2025Stocks to watch: BEL, Vodafone Idea, Arvind Fashions among shares in focus today
1 min read . 19 May 2025Three stocks to buy: Ankush Bajaj's expert recommendations for 23 April
5 min read . 23 Apr 2025Bajaj Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 542.6
- Selling/ General/ Admin Expenses Total
- 57.06
- Depreciation/ Amortization
- 27.92
- Other Operating Expenses Total
- 116.67
- Total Operating Expense
- 488.09
- Operating Income
- 54.51
- Net Income Before Taxes
- 46.01
- Net Income
- 39.5
- Diluted Normalized EPS
- 14.26
- Period
- 2025
- Total Assets
- 833.05
- Total Liabilities
- 366.88
- Total Equity
- 466.16
- Tangible Book Valueper Share Common Eq
- 147.15
- Period
- 2025
- Cashfrom Operating Activities
- 21.62
- Cashfrom Investing Activities
- -14.82
- Cashfrom Financing Activities
- -6.38
- Net Changein Cash
- 0.43
- Period
- 2024
- Total Revenue
- 473.42
- Selling/ General/ Admin Expenses Total
- 141.68
- Depreciation/ Amortization
- 27.62
- Other Operating Expenses Total
- 0.58
- Total Operating Expense
- 462.65
- Operating Income
- 10.76
- Net Income Before Taxes
- -16.68
- Net Income
- -83.79
- Diluted Normalized EPS
- 3.75
- Period
- 2024
- Total Assets
- 765.13
- Total Liabilities
- 486.77
- Total Equity
- 278.36
- Tangible Book Valueper Share Common Eq
- 100.2
- Period
- 2024
- Cashfrom Operating Activities
- 92.29
- Cashfrom Investing Activities
- -11.24
- Cashfrom Financing Activities
- -96.6
- Net Changein Cash
- -15.55
- Period
- 2023
- Total Revenue
- 645.8
- Selling/ General/ Admin Expenses Total
- 150.95
- Depreciation/ Amortization
- 17.21
- Other Operating Expenses Total
- 0.66
- Total Operating Expense
- 550.78
- Operating Income
- 95.02
- Net Income Before Taxes
- 78.18
- Net Income
- 43.02
- Diluted Normalized EPS
- 22.77
- Period
- 2023
- Total Assets
- 897.66
- Total Liabilities
- 529.97
- Total Equity
- 367.69
- Tangible Book Valueper Share Common Eq
- 132.73
- Period
- 2023
- Cashfrom Operating Activities
- -22.19
- Cashfrom Investing Activities
- -93.43
- Cashfrom Financing Activities
- 131.37
- Net Changein Cash
- 15.75
- Period
- 2022
- Total Revenue
- 679.89
- Selling/ General/ Admin Expenses Total
- 63.11
- Depreciation/ Amortization
- 17.64
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 576.8
- Operating Income
- 103.09
- Net Income Before Taxes
- 89.68
- Net Income
- 71.39
- Diluted Normalized EPS
- 25.86
- Period
- 2022
- Total Assets
- 721.1
- Total Liabilities
- 392.62
- Total Equity
- 328.49
- Tangible Book Valueper Share Common Eq
- 119.02
- Period
- 2022
- Cashfrom Operating Activities
- 0.69
- Cashfrom Investing Activities
- -74.8
- Cashfrom Financing Activities
- 61.85
- Net Changein Cash
- -12.27
- Period
- 2021
- Total Revenue
- 656.98
- Selling/ General/ Admin Expenses Total
- 56.39
- Depreciation/ Amortization
- 16.12
- Other Operating Expenses Total
- -0.1
- Total Operating Expense
- 536.54
- Operating Income
- 120.44
- Net Income Before Taxes
- 118.82
- Net Income
- 83.11
- Diluted Normalized EPS
- 30.11
- Period
- 2021
- Total Assets
- 525.63
- Total Liabilities
- 267.22
- Total Equity
- 258.41
- Tangible Book Valueper Share Common Eq
- 187.26
- Period
- 2021
- Cashfrom Operating Activities
- 43.56
- Cashfrom Investing Activities
- -108.93
- Cashfrom Financing Activities
- 75.46
- Net Changein Cash
- 10.08
- Period
- 2020
- Total Revenue
- 410.01
- Selling/ General/ Admin Expenses Total
- 28.18
- Depreciation/ Amortization
- 12.12
- Other Operating Expenses Total
- 15.19
- Total Operating Expense
- 370.68
- Operating Income
- 39.33
- Net Income Before Taxes
- 36.06
- Net Income
- 25.24
- Diluted Normalized EPS
- 9.15
- Period
- 2020
- Total Assets
- 325.75
- Total Liabilities
- 174.14
- Total Equity
- 151.61
- Tangible Book Valueper Share Common Eq
- 109.87
- Period
- 2020
- Cashfrom Operating Activities
- 20.57
- Cashfrom Investing Activities
- -27.56
- Cashfrom Financing Activities
- 3.28
- Net Changein Cash
- -3.7
- Period
- 2019
- Total Revenue
- 370.17
- Selling/ General/ Admin Expenses Total
- 38.96
- Depreciation/ Amortization
- 11.41
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 336.1
- Operating Income
- 34.08
- Net Income Before Taxes
- 24.17
- Net Income
- 16.31
- Diluted Normalized EPS
- 5.95
- Period
- 2019
- Total Assets
- 266.85
- Total Liabilities
- 137.74
- Total Equity
- 129.11
- Tangible Book Valueper Share Common Eq
- 93.56
- Period
- 2019
- Cashfrom Operating Activities
- 25.17
- Cashfrom Investing Activities
- -13.03
- Cashfrom Financing Activities
- -12.57
- Net Changein Cash
- -0.42
- Period
- 2025-03-31
- Total Revenue
- 154.47
- Selling/ General/ Admin Expenses Total
- 15.71
- Depreciation/ Amortization
- 7.53
- Other Operating Expenses Total
- 33.04
- Total Operating Expense
- 150.25
- Operating Income
- 4.23
- Net Income Before Taxes
- 11.72
- Net Income
- 11.18
- Diluted Normalized EPS
- 3.59
- Period
- 2025-03-31
- Total Assets
- 833.05
- Total Liabilities
- 366.88
- Total Equity
- 466.16
- Tangible Book Valueper Share Common Eq
- 147.15
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 21.62
- Cashfrom Investing Activities
- -14.82
- Cashfrom Financing Activities
- -6.38
- Net Changein Cash
- 0.43
- Period
- 2024-12-31
- Total Revenue
- 122.79
- Selling/ General/ Admin Expenses Total
- 14.65
- Depreciation/ Amortization
- 6.85
- Other Operating Expenses Total
- 25.59
- Total Operating Expense
- 108
- Operating Income
- 14.79
- Net Income Before Taxes
- 11.65
- Net Income
- 11.72
- Diluted Normalized EPS
- 4.65
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 133.09
- Selling/ General/ Admin Expenses Total
- 13.99
- Depreciation/ Amortization
- 6.81
- Other Operating Expenses Total
- 28.59
- Total Operating Expense
- 115.37
- Operating Income
- 17.72
- Net Income Before Taxes
- 12.45
- Net Income
- 9.46
- Diluted Normalized EPS
- 2.96
- Period
- 2024-09-30
- Total Assets
- 803.95
- Total Liabilities
- 358.12
- Total Equity
- 445.83
- Tangible Book Valueper Share Common Eq
- 140.6
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 25.71
- Cashfrom Investing Activities
- -5.78
- Cashfrom Financing Activities
- -0.64
- Net Changein Cash
- 19.29
- Period
- 2024-06-30
- Total Revenue
- 132.25
- Selling/ General/ Admin Expenses Total
- 12.71
- Depreciation/ Amortization
- 6.73
- Other Operating Expenses Total
- 29.45
- Total Operating Expense
- 114.47
- Operating Income
- 17.77
- Net Income Before Taxes
- 10.18
- Net Income
- 7.13
- Diluted Normalized EPS
- 2.91
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 133.9
- Selling/ General/ Admin Expenses Total
- 10.62
- Depreciation/ Amortization
- 7.3
- Other Operating Expenses Total
- 23.55
- Total Operating Expense
- 169.49
- Operating Income
- -35.59
- Net Income Before Taxes
- -35.15
- Net Income
- -29.92
- Diluted Normalized EPS
- -1.15
- Period
- 2024-03-31
- Total Assets
- 765.13
- Total Liabilities
- 486.77
- Total Equity
- 278.36
- Tangible Book Valueper Share Common Eq
- 100.2
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 92.29
- Cashfrom Investing Activities
- -11.24
- Cashfrom Financing Activities
- -96.6
- Net Changein Cash
- -15.55
- Period
- 2023-12-31
- Total Revenue
- 108.57
- Selling/ General/ Admin Expenses Total
- 11.65
- Depreciation/ Amortization
- 7.35
- Other Operating Expenses Total
- 26.1
- Total Operating Expense
- 96.39
- Operating Income
- 12.18
- Net Income Before Taxes
- 6.33
- Net Income
- -2.2
- Diluted Normalized EPS
- 2.01
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Bajaj Healthcare Technical
Moving Average
SMA
- 5 Day527.74
- 10 Day526.23
- 20 Day529.18
- 50 Day552.71
- 100 Day597.33
- 300 Day517.12
Bajaj Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Syncom Formulations (india)
- 19.26
- 0.02
- 0.1
- 27.94
- 12.31
- 1795.51
- Ttk Health Care
- 1281.5
- 8.3
- 0.65
- 1923
- 991
- 1810.8
- Bajaj Healthcare
- 518.9
- -4.4
- -0.84
- 744.9
- 312.7
- 1639.16
- Bliss Gvs Pharma
- 157.05
- 8.25
- 5.54
- 184.95
- 101
- 1652.62
- Hester Biosciences
- 1868
- 51.25
- 2.82
- 3375.45
- 1246.75
- 1589.69
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Syncom Formulations (india)
- 33.76
- 5.29
- 12
- 10.15
- Ttk Health Care
- 25.25
- 1.69
- 7.56
- 7.29
- Bajaj Healthcare
- 36.71
- 3.55
- 16
- 8.22
- Bliss Gvs Pharma
- 18.72
- 1.49
- 7.19
- 9.45
- Hester Biosciences
- 53.74
- 4.93
- 11.14
- 11.44
Bajaj Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results & Final Dividend
- 11-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 19-Sept-24
- Others
- 14-Aug-24
- Quarterly Results & ESOP
- 10-Jul-24
- Preferential issue of shares
- 24-May-24
- Audited Results & Final Dividend
- 09-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 17-Sept-24
- AGM
- 07-Aug-24
- 16-Jul-24
- EGM
- 30-Sept-23
- 08-Sept-23
- AGM
- 05-Aug-23
- 06-Jul-23
- POM
- 30-Sept-21
- 03-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 26-May-25
- -
- -
- 1
- 24-May-24
- -
- 23-Sept-24
- 1
- 30-May-23
- -
- 22-Sept-23
- 1
- 17-May-22
- -
- 22-Sept-22
- 1.5
- 10-Jun-21
- 29-Sept-21
- 28-Sept-21
- 0.5
- 09-Jun-21
- 29-Sept-21
- 28-Sept-21
- 0.5

- Ex-Splits
- Old FV
- New FV
- Description
- 28-Sept-21
- 10
- 5
- Stock split from Rs. 10/- to Rs. 5/-.
